Infertility Drugs Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2024-2032)

Infertility Drugs Market Outlook

• The rapid increase in infertility rates and expansion of the endocrine-active chemicals market provide momentum to support growth and increase the demand for fertility drugs and treatments. The infertility drugs market is growing in key regions of the world, due to increasing requirements for non-invasive fertility options.
• The United States is expected to account for a major share in the infertility drugs market, owing to the high rates of infertility, steady research investments, and favorable healthcare system.
• The market growth is impacted by the rising awareness of infertility-related issues, supported by the government and company-driven initiatives.

Infertility Drugs Market Overview

Infertility drugs help in managing and treating infertility issues in both males and females. It can help in stimulating ovulation in women and balancing hormone levels necessary for reproductive health. In males, it may increase sperm count. Clomiphene citrate gonadotropins aromatase inhibitors are amongst the most frequently used medications that help infertility.

Infertility Drugs Market Growth Drivers

Rising Cases of Infertility among Men and Women to Boost the Growth of the Industry

According to the World Health Organisation's 2023 report, 1 in 6 people across the world are expected to witness difficulties conceiving, highlighting the dire requirement of accessible yet quality fertility care. The rising prevalence of infertility-related diseases such as hormonal imbalances, endometriosis, and ovarian cysts is a key factor driving the demand for infertility drugs. In addition, fertility issues are further worsened by stress, obesity, and smoking.

Infertility Drugs Market Trends

Rise in Partnerships Between Key Market Players

In June 2024, Ferring Pharmaceuticals collaborated with Posterity Health to introduce a Male Fertility program on the Fertility Out Loud platform. This program provides an online evaluation to assist men in comprehending their fertility condition with private surveys and educational materials developed by reproductive urologists. The goal of the program is to reduce the stigma related to male infertility, prompt early assessment, and support fair fertility procedures for couples, ultimately creating a more inclusive and efficient fertility experience.

Growing Popularity of Personalized Fertility Treatments

Fertility treatments now rely more on personalized medicine practice with patient-specific drug regimens determined by an individual's genetic, hormonal, and health characteristics. It is intended to enhance the effectiveness and reduce side effects from the treatment.

Adoption of Telemedicine to Meet the Rising Infertility Drugs Market Demand

The use of online consultations in medicine is becoming popular, providing greater access to patients located far from physical clinics. Fertility experts can also diagnose and treat patients from a distance using telemedicine services, providing increased convenience and the possibility of reduced costs for treatment.

Increasing Demand for Non-Invasive and Minimally Invasive Treatment Options

Fewer patients are willing to risk higher invasive fertility treatments. This need is making pharmaceutical companies invent oral and injectable forms of the drugs providing safe results with fewer procedural hazards.

Infertility Drugs Market Segmentation

Market Breakup by Drug Class

• Gonadotrophins
• Aromatase Inhibitors
• Selective Estrogen Receptor Modulators (SERMs)
• Biguanides
• Others

Market Breakup by Gender

• Male
• Female

Market Breakup by Route of Administration

• Oral
• Injectable

Market Breakup by Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Market Breakup by Region

• United States
• EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
• Japan
• India

Infertility Drugs Market Share

The Gonadotrophins Segment Based on Drug Class Holds a Significant Share in the Market

The market is segmented by drug class into gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, and others. The gonadotrophins drug class is anticipated to be the dominant segment among these. The market share can be attributed to its ability to considerably increase pregnancy chances in women. Women are also learning more about the decreased side effects of gonadotrophins, which boosts the market value of this segment.

Market Segmentation Based on Gender

Based on gender, the market is segmented into male and female. Among these, the female segment is expected to lead the market, as a large range of drugs is available for addressing female infertility issues. These drugs may involve ovulation stimulators, hormone treatments, and follicle-stimulating agents. In assisted reproductive technology (ART) procedures, such as in vitro fertilization (IVF), medications are more common for female patients.

Infertility Drugs Market Analysis by Region

The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and India. Among these, the United States is expected to dominate the market due to its high disease prevalence rates and funding for research. Such areas are underpinned by the aging population and lifestyle-related risks in market growth. Support from the government and healthcare systems driving market expansion as it leads in clinical trials is a pioneer in treating the disease with targeted therapies, and immunotherapies. Rising emphasis on early diagnosis and customized treatment options is driving the market.

Leading Players in the Infertility Drugs Market

The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:

Mankind Pharma

Established in New Delhi in 1991, Mankind Pharma is one of India's top-notch pharmaceutical companies. Its product range includes Siphene (clomphene citrate) which is an ovulation inducer widely used for female infertility. The fertility market in India as everywhere else is ever-growing and Mankind Pharma with its vision of treatment made affordable, ensures access to the widest range for the widest population.

Pfizer Inc.

Pfizer, which was established in 1849 and has its headquarters in New York City is a leading global pharmaceutical company as well. Menopur (menotropins) is a common drug in the company portfolio and is used to induce ovulation in women undergoing fertility treatment in the infertility drugs market.

Novartis AG

Novartis is headquartered in Basel, Switzerland, and was founded in 1996 as a pharmaceutical company specializing in specialty and generics. Infertility treatments from Novartis include hormone-based therapies to assist in ART procedures. The company provides a variety of patient solutions by delivering progressive infertility drugs around the world and creating patient-friendly approaches for use with fertility treatment.

Bayer AG

Bayer was founded in 1863 and is based in Leverkusen, Germany. It is best known for Puregon (follitropin beta), which is an artificial regimen that produces ovulation induction. Bayer's stronghold in hormone therapies is a leading combatant in the market and has already been conducting rigorous research aimed at developing cutting-edge solutions for female infertility as well as male infertility.

Other companies include Merck KGaA, Ferring Pharmaceuticals Inc., Thermo Fisher Scientific, Inc., THERAMEX HQ UK LIMITED, Teva Pharmaceuticals Industries Ltd., and Livzon Pharmaceutical Group Inc., among others.

Key Questions Answered in the Infertility Drugs Market

• What was the infertility drugs market value in 2023?
• What is the infertility drugs market forecast outlook for 2024- 2032?
• What are the regional markets covered in the EMR report?
• What is the market segmentation based on the drug class?
• What is the market segmentation based on the gender?
• What is the market breakup by route of administration?
• What is the market breakup based on the distribution channel?
• What major factors aid the infertility drugs market demand?
• What are the market's major drivers, opportunities, and restraints?
• Which regional market is expected to lead the market share in the forecast period?
• Which country is expected to experience expedited growth during the forecast period?
• What are the major infertility drugs market trends?
• How does the rise in the geriatric population impact the market size?
• Who are the key players in the infertility drugs market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
• Why are gonadotrophins widely used in infertility treatments?
• Which infertility drugs are specifically targeted for male patients?
• What are the benefits of oral infertility drugs?
• What role do hospital pharmacies play in infertility treatment distribution?
• Why is the United States a leading market for infertility drugs?
• How is India’s growing healthcare infrastructure impacting infertility drug demand?